ITIH1 and hepatocellular carcinoma: In line with our finding that high ITIH1 expression correlates with good clinical outcomes in HCC patients, both ITIH1 overexpression and recombinant ITIH1 treatment inhibited tumor metastasis and development without causing significant toxicity in mice, indicating the potential therapeutic effects of ITIH1.